[1]黄宝涛.可穿戴设备在心肌梗死患者随访管理中的应用[J].心血管病学进展,2022,(1):18-22.[doi:10.16806/j.cnki.issn.1004-3934.2022.1.005]
　HUANG Baotao.Application of Wearable Devices in Follow-Up Management of Patients After Myocardial Infarction[J].Advances in Cardiovascular Diseases,2022,(1):18-22.[doi:10.16806/j.cnki.issn.1004-3934.2022.1.005]
点击复制

可穿戴设备在心肌梗死患者随访管理中的应用()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2022年1期
页码:
18-22
栏目:
出版日期:
2022-01-25

文章信息/Info

Title:
Application of Wearable Devices in Follow-Up Management of Patients After Myocardial Infarction
作者:
黄宝涛
(四川大学华西医院心脏内科,四川 成都 610041)
Author(s):
HUANG Baotao
(Department of Cardiology,West China Hospital,Sichuan University,Chengdu 610041,Sichuan,China)
关键词:
可穿戴设备; 心肌梗死; 随访; 预后
Keywords:
Wearable devices; Myocardial infarction; Follow-up; Prognosis
DOI:
10.16806/j.cnki.issn.1004-3934.2022.1.005
摘要:
主动健康要求个体主动获得持续的健康能力，要求慢性病患者自发和积极地关注自身健康，参与到疾病管理中来。然而，常规随访手段不能满足心肌梗死患者的长期管理要求，患者对自己生命体征的把握，以及心血管健康状况、药物优化治疗方案和康复锻炼效果缺乏足够的了解手段。具有多种传感器的可穿戴设备为心肌梗死患者危险因素的管理、病情的监测和预警、预后的判断提供了手段，为患者和医生在随访期间的互相反馈架起了桥梁。未来有希望借助可穿戴设备指导患者的管理，改善心肌梗死患者的预后。
Abstract:
Active health requires healthy individuals to actively acquire the ability to maintain personal health,and requires patients with chronic diseases to pay close attention to their own health initiatively with joint participation in disease management. However,the routine follow-up procedures do not meet the demands of long-term management of patients with myocardial infarction. After hospital discharge,patients lack effective feedback models for understanding their own vital signs,cardiovascular health status,optimal drug treatment plan,and the effect of cardiac rehabilitation and exercise program. Wearable devices with a variety of sensors provide optional methods for the m anagement of cardiovascular risk factors,disease monitoring and early warning,predicting the prognosis and building bridges between doctors and patients. In the future,there is hope that wearable devices will guide patient management and improve the outcomes of patients with myocardial infarction.

参考文献/References:

[1]Sempionatto JR,Lin M,Yin L,et al. An epidermal patch for the simultaneous monitoring of haemodynamic and metabolic biomarkers[J]. Nat Biomed Eng,2021,5(7):737-748.

[2]Kamei T,Kanamori T,Yamamoto Y,et al. The use of wearable devices in chronic disease management to enhance adherence and improve telehealth outcomes:a systematic review and meta-analysis[J]. J Telemed Telecare,2020,Aug 20:1357633X20937573. DOI:10.1177/1357633X20937573. Epub ahead of print.

[3]Cho JH,Kwon HM,Park SE,et al. Protective effect of smoking cessation on subsequent myocardial infarction and ischemic stroke independent of weight gain:a nationwide cohort study[J]. PLoS One,2020,15(7):e0235276.

[4]Biery DW,Berman AN,Singh A,et al. Association of smoking cessation and survival among young adults with myocardial infarction in the partners YOUNG-MI registry[J]. JAMA Netw Open,2020,3(7):e209649.

[5]Imtiaz MH,Ramos-Garcia RI,Wattal S,et al. Wearable sensors for monitoring of cigarette smoking in free-living:a systematic review[J]. Sensors(Basel),2019,19(21):4678.

[6]Cole CA,Powers S,Tomko RL,et al. Quantification of smoking characteristics using smartwatch technology:pilot feasibility study of new technology[J]. JMIR Form Res,2021,5(2):e20464.

[7]Chow CK,Redfern J,Hillis GS,et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease:a randomized clinical trial[J]. JAMA,2015,314(12):1255-1263.

[8]Hong W, Lee WG. Wearable sensors for continuous oral cavity and dietary monitoring toward personalized healthcare and digital medicine[J]. Analyst,2021,145(24):7796-7808.

[9]Hassannejad H,Matrella G,Ciampolini P,et al. Automatic diet monitoring:a review of computer vision and wearable sensor-based methods[J]. Int J Food Sci Nutr,2017,68(6):656-670.

[10]Huang HY,Hsieh CY,Liu KC,et al. Fluid intake monitoring system using a wearable inertial sensor for fluid intake management[J]. Sensors(Basel),2020,20(22):6682.

[11]van Egmond K,Wright CJC,Livingston M,et al. Wearable transdermal alcohol monitors:a systematic review of detection validity,and relationship between transdermal and breath alcohol concentration and influencing factors[J]. Alcohol Clin Exp Res,2020,44(10):1918-1932.

[12]Dimitratos SM,German JB,Schaefer SE. Wearable technology to quantify the nutritional intake of adults:validation study[J]. JMIR Mhealth Uhealth,2020,8(7):e16405.

[13]Davies A,Chan V,Bauman A,et al. Using wearable cameras to monitor eating and drinking behaviours during transport journeys[J]. Eur J Nutr,2021,60(4):1875-1885.

[14]Jakicic JM,Davis KK,Rogers RJ,et al. Effect of wearable technology combined with a lifestyle intervention on long-term weight loss:the IDEA randomized clinical trial[J]. JAMA,2016,316(11):1161-1171.

[15]MacKinnon GE,Brittain EL. Mobile health technologies in cardiopulmonary disease[J]. Chest,2020,157(3):654-664.

[16]Ashur C,Cascino TM,Lewis C,et al. Do wearable activity trackers increase physical activity among cardiac rehabilitation participants? A SYSTEMATIC REVIEW AND META-ANALYSIS[J]. J Cardiopulm Rehabil Prev,2021,41(4):249-256.

[17]Nogic J,Thein PM,Cameron J,et al. The utility of personal activity trackers (Fitbit Charge 2) on exercise capacity in patients post acute coronary syndrome [UP-STEP ACS Trial]:a randomised controlled trial protocol[J]. BMC Cardiovasc Disord,2017,17(1):303.

[18]Hodkinson A,Kontopantelis E,Adeniji C,et al. Interventions using wearable physical activity trackers among adults with cardiometabolic conditions:a systematic review and meta-analysis[J]. JAMA Netw Open,2021,4(7):e2116382.

[19]Kelly JP,Ballew NG,Lin L,et al. Association of implantable device measured physical activity with hospitalization for heart?failure[J]. JACC Heart Fail,2020,8(4):280-288.

[20]Burch AE,Erath JW,Kutyifa V,et al. Decline in physical activity in the weeks preceding sustained ventricular arrhythmia in women[J]. Heart Rhythm O2,2020,1(4):283-287.

[21]Burch AE,D’Souza B,Gimbel JR,et al. Physical activity is reduced prior to ventricular arrhythmias in patients with a wearable cardioverter defibrillator[J]. Clin Cardiol,2020,43(1):60-65.

[22]Gao L,Lim ASP,Wong PM,et al. Fragmentation of rest/activity patterns in community-based elderly individuals predicts incident heart failure[J]. Nat Sci Sleep,2020,12:299-307.

[23]Kramer F,Butler J,Shah SJ,et al. Real-life multimarker monitoring in patients with heart failure:continuous remote monitoring of mobility and patient-reported outcomes as digital end points in future heart-failure trials[J]. Digit Biomark,2020,4(2):45-59.

[24]Maddison R,Cartledge S,Rogerson M,et al. Usefulness of wearable cameras as a tool to enhance chronic disease self-management:scoping review[J]. JMIR Mhealth Uhealth ,2019,7(1):e10371.

[25]Cartledge S,Rogerson M,Singh TKR,et al. Seeing is believing:the feasibility and acceptability of using wearable cameras to enhance self-management of heart failure[J]. Eur Heart J,2019,40(suppl 1):ehz747.0094.

[26]Kario K. Management of hypertension in the digital era:small wearable monitoring devices for remote blood pressure monitoring[J]. Hypertension,2020,76(3):640-650.

[27]Sana F,Isselbacher EM,Singh JP,et al. Wearable devices for ambulatory?cardiac monitoring:JACC state-of-the-art review[J]. J Am Coll Cardiol,2020,75(13):1582-1592.

[28]Omboni S,Panzeri E,Campolo L. E-health in hypertension management:an insight into the current and future role of blood pressure telemonitoring[J]. Curr Hypertens Rep,2020,22(6):42.

[29]Ivers NM,Schwalm JD, Bouck Z ,et al. Interventions supporting long term adherence and decreasing cardiovascular events after myocardial infarction (ISLAND):pragmatic randomised controlled trial [J]. BMJ,2020,369:m1731.

[30]Teymourian H,Parrilla M,Sempionatto JR,et al. Wearable electrochemical sensors for the monitoring and screening of drugs[J]. ACS Sens,2020,5(9):2679-2700.

[31]Chen C,Kehtarnavaz N,Jafari R. A medication adherence monitoring system for pill bottles based on a wearable inertial sensor[J]. Annu Int Conf IEEE Eng Med Biol Soc ,2014,2014:4983-4986.

[32]Marvel FA,Spaulding EM,Lee MA,et al. Digital health intervention in acute myocardial infarction[J]. Circ Cardiovasc Qual Outcomes,2021,14(7):e007741.

[33]Stehlik J,Schmalfuss C,Bozkurt B,et al. Continuous wearable monitoring analytics predict heart failure hospitalization:the LINK-HF Multicenter Study [J]. Circ Heart Fail,2020,13(3):e006513.

[34]Nunes-Ferreira A,Agostinho JR,Rigueira J,et al. Non-invasive telemonitoring improves outcomes in heart failure with reduced ejection fraction:a study in high-risk patients[J]. ESC Heart Fail,2020,7(6):3996-4004.

[35]Jen?a D,Melenovsk? V,Stehlik J,et al. Heart failure after myocardial infarction:incidence and predictors[J]. ESC Heart Fail,2021,8(1):222-237.

[36]Cuba-Gyllensten I,Gastelurrutia P,Riistama J,et al. A novel wearable vest for tracking pulmonary congestion in acutely decompensated heart failure[J]. Int J Cardiol,2014,177(1):199-201.

[37]Smeets CJP,Lee S,Groenendaal W,et al. The added value of in-hospital tracking of the efficacy of decongestion therapy and prognostic value of a wearable thoracic impedance sensor in acutely decompensated heart failure with volume overload:prospective cohort study[J]. JMIR Cardio,2020,4(1):e12141.

[38]Kim S,Iravantchi YS,Gajos KZ,et al. SwellFit:a Wearable Sensor for Patients with Congestive Heart Failure :In Proceedings of the Workshop on Interactive Systems in Healthcare(WISH),May 7,2016[C/OL].San Jose,CA,2016.https://dash.harvard.edu/handle/1/29405813.

[39]Inan OT,Baran Pouyan M,Javaid AQ,et al. Novel wearable seismocardiography and machine learning algorithms can assess clinical status of heart failure patients[J].Circ Heart Fail,2018,11(1):e004313.

相似文献/References:

[1]王铁华,郑景辉,莫云秋.蛋白质组学在心肌梗死中的研究进展[J].心血管病学进展,2015,(5):616.[doi:10.3969/j.issn.1004-3934.2015.05.024]
　WANG Tiehua,ZHENG Jinghui,MO Yunqiu.Research Progress of Proteomics in Myocardial Infarction[J].Advances in Cardiovascular Diseases,2015,(1):616.[doi:10.3969/j.issn.1004-3934.2015.05.024]
[2]孙洋.基质金属蛋白酶与心肌梗死后心脏重构[J].心血管病学进展,2019,(8):1094.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.006]
　SUN Yang.Matrix Metalloproteinases in Cardiac Remodeling after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(1):1094.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.006]
[3]陈丰 苏强 朱继金.高迁移率族蛋白B1在心脏炎症反应性疾病中的研究进展[J].心血管病学进展,2019,(8):1111.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.010]
　CHEN Feng,SU Qiang,ZHU Jijin.Research Progress of HMGB1 in Myocardial Inflammatory Reactivity Disease[J].Advances in Cardiovascular Diseases,2019,(1):1111.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.010]
[4]常文婧 王丽娜.Hippo通路在心脏发育、再生和疾病中的作用[J].心血管病学进展,2019,(8):1115.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.011]
　CHANG Wenjin,WANG Lina.Role of Hippo Pathway in Heart Development,Regeneration and Disease[J].Advances in Cardiovascular Diseases,2019,(1):1115.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.011]
[5]王宇 周思维 张莎 吴弘.植入型心律转复除颤器在心肌梗死后心脏性猝死中的研究进展[J].心血管病学进展,2020,(1):4.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.002]
　WANG Yu,ZHOU Siwei,ZHANG Sha,et al.Implantable Cardioverter Defibrillator in Sudden Cardiac Death after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(1):4.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.002]
[6]邹先明 赵然尊.长链非编码RNA ANRIL与心血管疾病的研究进展[J].心血管病学进展,2020,(2):167.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.017]
　ZOU Xianming,ZHAO Ranzun.Long Non-Coding RNA ANRIL and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(1):167.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.017]
[7]王茜 李晶洁.细胞学机制在调控心肌梗死后炎症反应中的研究进展[J].心血管病学进展,2020,(2):190.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.023]
　WANG QianLI Jingjie.Cytological Mechanisms in Regulation of The Post-infarction Inflammatory Response[J].Advances in Cardiovascular Diseases,2020,(1):190.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.023]
[8]黄柳,张瑞宁,田小超,等.内皮祖细胞与冠心病患者CD14CD16+单核细胞共培养后移植心肌梗死大鼠对血管密度及心肌梗死面积的影响[J].心血管病学进展,2020,(2):203.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.027]
　HUANG Liu,ZHANG Ruining,TIAN Xiaochao,et al.Effects of Co-cultured Endothelial Progenitor Cells and CD14++CD16+ Monocytes from Coronary Heart Disease Patients on Vascular Density and Myocardial Infarction Size in Transplanting Myocardial Infarction Rats[J].Advances in Cardiovascular Diseases,2020,(1):203.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.027]
[9]刘玉婷,贾锋鹏.骨膜蛋白与心血管疾病的研究进展[J].心血管病学进展,2020,(3):239.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.006]
　LIU Yuting,JIA Fengpeng.Roles of Periostin in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(1):239.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.006]
[10]谢建华,赵鸿泽,刘剑雄.MicroRNA在心肌梗死后左室重塑和心力衰竭发展中的研究现状[J].心血管病学进展,2020,(3):259.[doi:10.16806 /j.cnki.issn.1004-3934.2020.03.011]
　XIE Jianhua,ZHAO Hongze,LIU Jianxiong.MicroRNA in Development of Left Ventricular Remodeling and Heart Failure after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(1):259.[doi:10.16806 /j.cnki.issn.1004-3934.2020.03.011]

更新日期/Last Update: 2022-02-16